Profile
Sussex Research Laboratories Inc. (Ottawa, Canada) is a globally recognized specialist in Empowering Therapeutic Innovation Through Glycoscience. The company applies its expertise in glycodesign, glycan and glycoconjugate synthesis, and linker chemistries across a wide range of therapeutic areas, including vaccine development, protein and antibody engineering, and targeted drug delivery. With 30 years of pioneering experience as a Contract Research & Development (CRO) service provider, Sussex Research supports pharmaceutical and biopharmaceutical partners in applying glycotechnology to next-generation therapeutics, including oligonucleotide, peptide, protein, lipid, and small-molecule modalities, as well as lipid nanoparticle (LNP) technologies for modern drug design and delivery. The company is also widely recognized for its enabling product portfolio of advanced glycans, glycopeptides, glycoconjugates, and targeting ligand/linker systems.
Website
sussex-research.comContact
-
Dr. Brady Clark, Chief Executive Officer and FounderTel: +1 613-720-4402Email: info@sussex-research.com
-
-
-
-
-
Event details
Event contact
Participants
-
20/20 OptimEyes Technologies is developing OPT-101, a once-weekly, non-invasive glaucoma eye drop designed to… -
Altis Labs is the computational imaging company accelerating clinical trials with AI endpoints.… -
BioScript Solutions is a Canadian healthcare company committed to simplifying access to specialty care. BioScript… -
The Ottawa Hospital's Biotherapeutics Manufacturing Centre(BMC) is a cell and gene therapy… -
Custom Biologics provides regulatory compliant potency testing and assay services for all phases of… -
Dalriada is a Canadian small molecule discovery company focusing on unlocking challenging and undruggable targets… -
Located in Mississauga, Ontario, Eurofins CDMO Alphora delivers comprehensive solutions for small… -
Founded in 2004, Everest Clinical Research is a full-service contract research organization with more than 750… -
HDAX Therapeutics develops next-gen HDAC6 inhibitors for… -
i-RNA Corporation is a preclinical biotech developing siRNA… -
ImmunoBiochem is a pharma-partnered biotech developing novel degrader-antibody conjugate (DAC)… -
Medicenna is a clinical stage immunotherapy company developing novel and highly differentiated engineered long-… -
Noa Therapeutics is pioneering a breakthrough to the Aryl Hydrocarbon Receptor (AhR), a commercially… -
Nucro-Technics is a full-service Contract Support Organization that specializes in the conduct of both… -
Paradox Immunotherapeutics is a venture-backed, clinical-inflection biotech tackling protein misfolding diseases… -
PharmAla Biotech (CSE:… -
PlantForm develops and manufactures proteins, antibodies, and vaccines at low cost using its green, plant-based… -
For over 32 years, Q&C Services has been Canada’s largest privately owned pharmaceutical consulting firm. Its… -
QurCan Therapeutics is advancing the next wave of genetic medicines for CNS… -
Spiderwort Biotechnologies is a clinical-stage regenerative medicine company pioneering a differentiated class of… -
Sussex Research Laboratories Inc. (Ottawa, Canada) is a globally recognized specialist in Empowering Therapeutic…
-
SYNG has developed, EndoID a new first-in-class diagnostic test for Endometriosis. It is… -
YYZPharmatech Inc. (“YYZ”) reveals and validates novel, proximal, functional co-receptor drug…